Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms

Primer Autor
Brebi, Priscilla
Título
Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms
Editorial
FUTURE MEDICINE LTD
Revista
PHARMACOGENOMICS
Lenguaje
en
Tipo de Recurso
artículo de revisión
Derecho de Acceso
metadata
Description
This work was supported by National Commission for Scientific and Technological Research (CONICYT) under Grant 21201835 to ME Reyes, National Funding for Scientific and Technologic Development of Chile (FONDECYT) 3210687 to L Zanella, 3210629 to B Mora, 3180550 to K Buchegger and 1210440 to P Brebi. Direccion de Investigacion, Universidad de La Frontera (DIUFRO) DIM20 _0019 to L Zanella, DI20 _0160 to C Ili and DI20 _0128 to P Brebi. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
doi
10.2217/pgs-2021-0020
Formato Recurso
pdf
Palabras Claves
ADME gene
cancer
drug resistance
epigenetics
non-ADME gene
platinum-based drugs
Ubicación del archivo
http://dx.doi.org/10.2217/pgs-2021-0020
Categoría OCDE
Farmacología y farmacia
Materias
Gen ADME
cáncer
resistencia a los medicamentos
epigenética
gen no ADME
medicamentos a base de platino
Disciplinas de la OCDE
Farmocología y Farmacia
Id de Web of Science
WOS:000674610000001
Access Rights
metadata
Derechos de acceso
metadata
Título de la cita (Recomendado-único)
Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms
Identificador del recurso (Mandatado-único)
artículo de revisión
Versión del recurso (Recomendado-único)
version publicada
Editorial
FUTURE MEDICINE LTD
Revista/Libro
PHARMACOGENOMICS
Categoría WOS
Farmacología y farmacia
Idioma
en
ISSN
1462-2416
Descripción
This work was supported by National Commission for Scientific and Technological Research (CONICYT) under Grant 21201835 to ME Reyes, National Funding for Scientific and Technologic Development of Chile (FONDECYT) 3210687 to L Zanella, 3210629 to B Mora, 3180550 to K Buchegger and 1210440 to P Brebi. Direccion de Investigacion, Universidad de La Frontera (DIUFRO) DIM20 _0019 to L Zanella, DI20 _0160 to C Ili and DI20 _0128 to P Brebi. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Referencia del Financiador (Mandatado si es aplicable-repetible)
ANID CONICYT 21201835
ANID FONDECYT 3210687
ANID FONDECYT 3210629
ANID FONDECYT 3180550
ANID FONDECYT 1210440
UFRO DIUFRO DIM20-0019
UFRO DI20-0160
UFRO DI20-0128
Tipo de ruta
hibrido
Formato
pdf
Colecciones
Colección Publicaciones Científicas
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions